Allison Forrest1,2, Sam Afshari3, Nathan Franssen3, Naiim Ali3. 1. University of Vermont Medical Center, Burlington, VT, USA. Allison.Forrest@UVMhealth.org. 2. Department of Radiology, University of Vermont Medical Center, 111 Colchester Ave, Burlington, VT, 05401, USA. Allison.Forrest@UVMhealth.org. 3. University of Vermont Medical Center, Burlington, VT, USA.
Abstract
PURPOSE: Abdominal ultrasound is a cost-effective method for screening for hepatocellular carcinoma (HCC) in high-risk individuals. Currently, at many institutions the protocol for obtaining HCC screening ultrasounds includes a traditional examination of the right upper quadrant, including the pancreas and right kidney. There is no consensus on the role of imaging of extra-hepatic structures and there are limited data describing the frequency and clinical significance of incidental findings discovered during HCC screening. The purpose of this retrospective study is to assess the prevalence and significance of extra-hepatic incidental findings during HCC screening ultrasounds. METHODS: A single-center retrospective review of all right upper quadrant HCC screening ultrasounds identified 432 HCC screening ultrasounds performed on 294 adults over a 2.5-year period. Findings in all organs evaluated were recorded. Any incidental finding was classified as minor, moderate, or major clinical significance. RESULTS: At least one extra-hepatic finding was documented in 57.4% of examinations. The most common extra-hepatic findings occurred in the gallbladder (40.3%), most commonly gallstones (25.4%). Four moderate clinically significant incidental findings were recorded (0.9%). Only one of these incidental findings required specific imaging follow up (0.2%). No major clinical significance incidental findings were identified. CONCLUSIONS: Potentially clinically significant incidental findings during ultrasound HCC screenings are rare. Incidental findings identified on HCC screening did not result in significant additional follow-up imaging or interventions.
PURPOSE: Abdominal ultrasound is a cost-effective method for screening for hepatocellular carcinoma (HCC) in high-risk individuals. Currently, at many institutions the protocol for obtaining HCC screening ultrasounds includes a traditional examination of the right upper quadrant, including the pancreas and right kidney. There is no consensus on the role of imaging of extra-hepatic structures and there are limited data describing the frequency and clinical significance of incidental findings discovered during HCC screening. The purpose of this retrospective study is to assess the prevalence and significance of extra-hepatic incidental findings during HCC screening ultrasounds. METHODS: A single-center retrospective review of all right upper quadrant HCC screening ultrasounds identified 432 HCC screening ultrasounds performed on 294 adults over a 2.5-year period. Findings in all organs evaluated were recorded. Any incidental finding was classified as minor, moderate, or major clinical significance. RESULTS: At least one extra-hepatic finding was documented in 57.4% of examinations. The most common extra-hepatic findings occurred in the gallbladder (40.3%), most commonly gallstones (25.4%). Four moderate clinically significant incidental findings were recorded (0.9%). Only one of these incidental findings required specific imaging follow up (0.2%). No major clinical significance incidental findings were identified. CONCLUSIONS: Potentially clinically significant incidental findings during ultrasound HCC screenings are rare. Incidental findings identified on HCC screening did not result in significant additional follow-up imaging or interventions.
Authors: Nicholas M Orme; Joel G Fletcher; Hassan A Siddiki; W Scott Harmsen; Megan M O'Byrne; John D Port; William J Tremaine; Henry C Pitot; Elizabeth G McFarland; Marguerite E Robinson; Barbara A Koenig; Bernard F King; Susan M Wolf Journal: Arch Intern Med Date: 2010-09-27
Authors: Patrick O Richard; Philippe D Violette; Michael A S Jewett; Frederic Pouliot; Michael Leveridge; Alan So; Thomas F Whelan; Ricardo Rendon; Antonio Finelli Journal: Can Urol Assoc J Date: 2017-03-16 Impact factor: 1.862
Authors: Alessandro Cucchetti; Franco Trevisani; Matteo Cescon; Giorgio Ercolani; Fabio Farinati; Paolo Del Poggio; Gianludovico Rapaccini; Maria Anna Di Nolfo; Luisa Benvegnù; Marco Zoli; Franco Borzio; Edoardo Giovanni Giannini; Eugenio Caturelli; Maria Chiaramonte; Antonio Daniele Pinna Journal: J Hepatol Date: 2012-01-13 Impact factor: 25.083
Authors: Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach Journal: Hepatology Date: 2018-08 Impact factor: 17.425
Authors: Lincoln L Berland; Stuart G Silverman; Richard M Gore; William W Mayo-Smith; Alec J Megibow; Judy Yee; James A Brink; Mark E Baker; Michael P Federle; W Dennis Foley; Isaac R Francis; Brian R Herts; Gary M Israel; Glenn Krinsky; Joel F Platt; William P Shuman; Andrew J Taylor Journal: J Am Coll Radiol Date: 2010-10 Impact factor: 5.532
Authors: Shuchi K Rodgers; David T Fetzer; Helena Gabriel; James H Seow; Hailey H Choi; Katherine E Maturen; Ashish P Wasnik; Tara A Morgan; Nirvikar Dahiya; Mary K O'Boyle; Yuko Kono; Claude B Sirlin; Aya Kamaya Journal: Radiographics Date: 2019 May-Jun Impact factor: 5.333